XPeng's Graz Trial Run Sets Stage for Paris Debut as Shares Sit Near Yearly Lows

XPeng completed a trial run of its G9L at Magna's Graz plant and will reveal European pricing at the Paris Motor Show on 12 October.

XPeng has quietly pushed its European manufacturing plans forward, completing a trial production run of its G9L SUV at Magna's facility in Graz, Austria. The vehicle becomes the fourth XPeng model to roll off that line, following the G6, G9 and P7+. The move signals that the Chinese automaker is laying the groundwork for a European sales push before it has even revealed what the car will cost.

That pricing question will be answered on 12 October, when the G9L gets its global premiere at the Paris Motor Show. XPeng intends to open order books for European customers on the same day and disclose official sticker prices. The company is also using the Paris stage to showcase its broader technology stack built around physical artificial intelligence.

Deliveries Provide the Backdrop

The product offensive rests on a delivery machine that has been gathering speed at home. XPeng shipped 41,256 vehicles in September, pushing its third-quarter total to 118,390 units — a 15% sequential gain over the prior quarter. The MONA L03 did much of the heavy lifting, clearing the 10,000-unit mark during September alone.

Volume of that scale helps XPeng absorb fixed production costs and eases some of the margin squeeze inflicted by China's brutal price war. Yet cheaper, high-volume models like the L03 cut both ways: they drive growth while typically diluting profitability. Investors are therefore focused less on the headline delivery figure than on whether the pace can be sustained.

Autonomy Ambitions Take Shape

Beyond metal and margins, XPeng is assembling a robotaxi business under the YOYO brand. The company has launched an online registration channel in China for autonomous rides, with access granted on an invitation-only basis. It is an early-stage effort, but one that feeds the narrative that XPeng's software capabilities could eventually travel beyond its home market.

JPMorgan Turns Cautious

Not everyone is convinced the story is about to turn. On 29 September, JPMorgan analyst Nick Lai downgraded the stock from Overweight to Neutral and slashed his price target from $24 to $11.50. Lai pointed to persistent weakness in China's auto sector through the second half of 2026 and structural headwinds that could stretch into 2027. Soft domestic demand, rising procurement costs and policy uncertainty all feature in his assessment.

Trade barriers add another layer of friction to overseas expansion. Should European demand fall short of plan, XPeng risks being stuck in the same destructive pricing battle it faces at home. On 2 October, the shares touched a fresh 52-week low of EUR 8.16.

Where the Stock Stands

The market has so far shown little enthusiasm for the operational progress. XPeng's share price is down roughly 52% to 53% year-to-date, trading at EUR 8.41 in recent sessions and EUR 8.60 in pre-market activity. The muted reaction suggests investors want harder evidence — durable profitability and a genuine European foothold — before buying into the recovery story.

That makes 12 October a pivotal date. The Paris premiere, the European pricing announcement and the opening of G9L orders will together shape expectations for the closing quarter. If pre-orders come in strong, XPeng gains credibility for its international growth thesis and reduces its reliance on Chinese pricing pressure. If they disappoint, the stock could face renewed selling. For now, the shares are holding above that recent low — and the market is waiting to see which way the Paris verdict breaks.